By [ad_1]
The company has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, Alembic Pharmaceuticals said in a statement.
[ad_2]
What is your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
